Your browser doesn't support javascript.
loading
Current status and future perspective of sonodynamic therapy for cancer.
Sofuni, Atsushi; Itoi, Takao.
Afiliación
  • Sofuni A; Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku Shinjuku-ku, Tokyo, 160-0023, Japan. a-sofuni@amy.hi-ho.ne.jp.
  • Itoi T; Department of Gastroenterology and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku Shinjuku-ku, Tokyo, 160-0023, Japan.
Article en En | MEDLINE | ID: mdl-36224458
There is a tremendous need for prevention and effective treatment of cancer due to the associated morbidity and mortality. In this study, we introduce sonodynamic therapy (SDT), which is expected to be a new cancer treatment modality. SDT is a promising option for minimally invasive treatment of solid tumors and comprises three different components: sonosensitizers, ultrasound, and molecular oxygen. These components are harmless individually, but in combination they generate cytotoxic reactive oxygen species (ROS). We will explore the molecular mechanism by which SDT kills cancer cells, the class of sonosensitizers, drug delivery methods, and in vitro and in vivo studies. At the same time, we will highlight clinical applications for cancer treatment. The progress of SDT research suggests that it has the potential to become an advanced field of cancer treatment in clinical application. In this article, we will focus on the mechanism of action of SDT and its application to cancer treatment, and explain key factors to aid in developing strategies for future SDT development.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Med Ultrason (2001) Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Med Ultrason (2001) Año: 2022 Tipo del documento: Article País de afiliación: Japón